Title: Septra - FDA prescribing information, side effects and uses
Headings: Septra
Septra
On This Page
Septra Description
Septra - Clinical Pharmacology
Geriatric Pharmacokinetics:
Microbiology:
Susceptibility Testing:
Indications and Usage for Septra
Urinary Tract Infections:
Acute Otitis Media:
Acute Exacerbations of Chronic Bronchitis in Adults:
Travelers' Diarrhea in Adults:
Shigellosis:
Pneumocystis Carinii Pneumonia:
Contraindications
Warnings
Adjunctive Treatment with Leucovorin for Pneumocystis jiroveci pneumonia
Precautions
General
Use in the Elderly:
Use in the Treatment of and Prophylaxis for Pneumocystis carinii Pneumonia in Patients with Acquired Immunodeficiency Syndrome (AIDS):
Information for Patients:
Laboratory Tests:
Drug Interactions:
Drug/Laboratory Test Interactions:
Carcinogenesis, Mutagenesis, Impairment of Fertility:
Pregnancy
Teratogenic Effects:
Nonteratogenic Effects:
Nursing Mothers:
Pediatric Use:
Geriatric Use:
Adverse Reactions
Hematologic:
Allergic:
Gastrointestinal:
Genitourinary:
Metabolic:
Neurologic:
Psychiatric:
Endocrine:
Musculoskeletal:
Respiratory System:
Miscellaneous:
Overdosage
Acute:
Chronic:
Septra Dosage and Administration
Urinary Tract Infections and Shigellosis in Adults and Pediatric Patients and Acute Otitis Media in Pediatric Patients:
Acute Exacerbations of Chronic Bronchitis in Adults:
Travelers' Diarrhea in Adults:
Pneumocystis Carinii Pneumonia:
Treatment:
Prophylaxis:
How is Septra Supplied
REFERENCES
PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label
100 Tablets
PRINCIPAL DISPLAY PANEL - 20 Tablet Bottle Label
PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label
100 Tablets
PRINCIPAL DISPLAY PANEL - 500 Tablet Bottle Label
Frequently asked questions
More about Septra (sulfamethoxazole / trimethoprim)
Consumer resources
Professional resources
Other brands
Other Formulations
Related treatment guides

Content: Septra - FDA prescribing information, side effects and uses
Professionals
FDA PI
Septra
Print Save
Septra
Generic Name: trimethoprim and sulfamethoxazole
Dosage Form: tablet
Medically reviewed by Drugs.com. Last updated on April 21, 2021. Overview
Side Effects
Dosage
Professional
Interactions
More
On This Page
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings
Precautions
Patient Counseling Information
Drug Interactions
Adverse Reactions/Side Effects
Overdosage
Dosage and Administration
How Supplied/Storage and Handling
References
Expand
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Septra and other antibacterial drugs, Septra should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. Septra Description
Septra (trimethoprim and sulfamethoxazole) is a synthetic antibacterial combination product. Each Septra Tablet contains 80 mg trimethoprim and 400 mg sulfamethoxazole and the inactive ingredients docusate sodium (0.4 mg per tablet), FD&C Red No. 40, magnesium stearate, povidone, and sodium starch glycolate. Each Septra DS (double strength) Tablet contains 160 mg trimethoprim and 800 mg sulfamethoxazole and the inactive ingredients docusate sodium (0.8 mg per tablet), FD&C Red No. 40, magnesium stearate, povidone, and sodium starch glycolate.